DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Gourgou-Bourgade S, Bascoul-Mollevi C, Desseigne F et al.
Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.
J Clin Oncol 2013;
31: 23-29
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.